The Journal of Immunology,
Journal Year:
2021,
Volume and Issue:
206(2), P. 257 - 263
Published: Jan. 1, 2021
Stromal
cells
have
for
a
long
time
been
viewed
as
structural
that
support
distinct
compartments
within
lymphoid
tissues
and
little
more.
Instead,
an
active
cross-talk
between
endothelial
fibroblastic
stromal
drives
the
maturation
of
niches,
relationship
is
recapitulated
during
lymph
node
organogenesis,
steady-state
conditions,
following
inflammation.
In
this
review,
we
go
over
recent
advances
in
genetic
models
high-resolution
transcriptomic
analyses
propelled
finer
resolution
cell
infrastructure
nodes,
revealing
subsets
are
strategically
positioned
to
deliver
catered
mixture
niche
factors
interacting
immune
populations.
Moreover,
discuss
how
changes
activation
state
poised
cell-underpinned
niches
rather
than
on-demand
differentiation
new
govern
efficient
interaction
Ag,
APC,
cognate
B
T
lymphocytes
adaptive
responses.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
33(26)
Published: May 19, 2021
Abstract
A
major
challenge
in
vaccine
delivery
is
to
achieve
robust
lymph‐node
(LN)
accumulation,
which
can
capitalize
on
concentrated
immunocytes
and
cytokines
LNs
stimulate
the
onset
persistence
of
adaptive
immune
responses.
Previous
attempts
at
developing
systems
have
focused
sizes,
charges,
or
surface
ligands
but
not
their
deformability.
In
fact,
LN
homing
antigen‐presenting
cells
depends
deformability
pass
through
cellular
gaps.
Herein,
albumin‐stabilized
emulsions
engineered.
Owing
self‐adaptive
deformability,
droplets
(≈330
nm)
attach
deform
between
adjust
sizes
endothelial
gaps
(20–100
nm),
favoring
direct
transfer
(intercellular
pathway).
Additionally,
owing
relatively
large
some
be
retained
administration
sites
for
potent
antigen
uptake
activation
APCs
as
well
LN‐targeted
vaccines
(intracellular
Compared
with
solid
particles,
dual
strategy
evidently
enhances
accumulation
drainage,
potently
stimulates
responses,
increases
survival
rate
tumor‐bearing
mice.
Thus,
may
offer
an
efficient
targeting
enhanced
vaccinations.
Cellular and Molecular Life Sciences,
Journal Year:
2021,
Volume and Issue:
78(16), P. 5987 - 6002
Published: July 9, 2021
Abstract
Lymph
node
metastasis
is
a
crucial
prognostic
parameter
in
many
different
types
of
cancers
and
gateway
for
further
dissemination
to
distant
organs.
Prior
metastatic
dissemination,
the
primary
tumor
prepares
remodeling
draining
(sentinel)
lymph
by
secreting
soluble
factors
or
releasing
extracellular
vesicles
that
are
transported
lymphatic
vessels.
These
important
changes
occur
before
appearance
first
cell
create
what
known
as
pre-metastatic
niche
giving
rise
subsequent
survival
growth
cells.
In
this
review,
structure,
matrix
composition
emerging
heterogeneity
cells
forming
it
described.
Current
knowledge
major
cellular
molecular
processes
associated
with
nodal
formation,
including
lymphangiogenesis,
remodeling,
immunosuppressive
enlisting
nodes
additionally
summarized.
Finally,
future
directions
research
could
possibly
take
clinical
impact
discussed.
The Journal of Experimental Medicine,
Journal Year:
2021,
Volume and Issue:
218(5)
Published: April 5, 2021
IL-17
was
discovered
nearly
30
yr
ago,
but
it
has
only
been
recently
appreciated
that
a
key
function
of
this
cytokine
is
to
orchestrate
cellular
and
organismal
metabolism.
Indeed,
metabolic
regulation
integrated
into
both
the
physiological
pathogenic
aspects
responses.
Thus,
understanding
interplay
between
downstream
processes
could
ultimately
inform
therapeutic
opportunities
for
diseases
involving
IL-17,
including
some
not
traditionally
linked
pathway.
Here,
we
discuss
emerging
pathophysiological
roles
related
metabolism,
signal
transduction.
Annals of Oncology,
Journal Year:
2022,
Volume and Issue:
34(2), P. 186 - 199
Published: Nov. 17, 2022
Primary
central
nervous
system
lymphoma
(PCNSL)
is
a
rare
and
distinct
entity
within
diffuse
large
B-cell
presenting
with
variable
response
rates
probably
to
underlying
molecular
heterogeneity.To
identify
characterize
PCNSL
heterogeneity
facilitate
clinical
translation,
we
carried
out
comprehensive
multi-omic
analysis
[whole-exome
sequencing,
RNA
sequencing
(RNA-seq),
methylation
features]
in
discovery
cohort
of
147
fresh-frozen
(FF)
immunocompetent
PCNSLs
validation
formalin-fixed,
paraffin-embedded
(FFPE)
93
RNA-seq
clinico-radiological
data.Consensus
clustering
data
uncovered
concordant
classification
four
robust,
non-overlapping,
prognostically
significant
clusters
(CS).
The
CS1
CS2
groups
presented
an
immune-cold
hypermethylated
profile
but
behavior.
'immune-hot'
CS4
group,
enriched
mutations
increasing
the
Janus
kinase
(JAK)-signal
transducer
activator
transcription
(STAT)
nuclear
factor-κB
activity,
had
most
favorable
outcome,
while
heterogeneous-immune
CS3
group
worse
prognosis
due
its
association
meningeal
infiltration
HIST1H1E
mutations.
was
characterized
by
high
Polycomb
repressive
complex
2
activity
CDKN2A/B
loss
leading
higher
proliferation
activity.
Integrated
on
proposed
targets
suggests
potential
use
immune
checkpoint
inhibitors/JAK1
inhibitors
for
CS4,
cyclin
D-Cdk4,6
plus
phosphoinositide
3-kinase
(PI3K)
CS1,
lenalidomide/demethylating
drugs
CS2,
enhancer
zeste
polycomb
subunit
(EZH2)
CS3.
We
developed
algorithm
subtypes
using
from
either
FFPE
or
FF
tissue.The
integration
genome-wide
revealed
patterns
distinctive
prognostic
impact
that
provides
basis
future
stratification
subtype-based
targeted
interventions.
Journal of Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: July 23, 2023
Abstract
Therapeutic
tumor
vaccines
have
attracted
considerable
attention
in
the
past
decade;
they
can
induce
regression,
eradicate
minimal
residual
disease,
establish
lasting
immune
memory
and
avoid
non-specific
adverse
side
effects.
However,
challenge
field
of
therapeutic
is
ensuring
delivery
components
to
lymph
nodes
(LNs)
activate
cells.
The
clinical
response
rate
traditional
falls
short
expectations
due
inadequate
node
delivery.
With
rapid
development
nanotechnology,
a
large
number
nanoplatform-based
LN-targeting
nanovaccines
been
exploited
for
optimizing
immunotherapies.
In
addition,
some
possess
non-invasive
visualization
performance,
which
benefit
understanding
kinetics
nanovaccine
exposure
LNs.
Herein,
we
present
parameters
nanoplatforms,
such
as
size,
surface
modification,
shape,
deformability,
affect
functions
nanovaccines.
recent
advances
nanoplatforms
with
different
promoting
are
also
summarized.
Furthermore,
emerging
LNs-targeting
nanoplatform-mediated
imaging
strategies
both
improve
targeting
performance
enhance
quality
LN
discussed.
Finally,
summarize
prospects
challenges
/or
strategies,
optimize
efficacy
Journal of Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Nov. 20, 2023
Photoacoustic
imaging
(PAI)
is
a
successful
clinical
platform
for
management
of
cancer
and
other
health
conditions
that
has
seen
significant
progress
in
the
past
decade.
However,
translation
PAI
based
methods
are
still
under
scrutiny
as
quality
information
derived
from
PA
images
not
on
par
with
methods.
Hence,
to
improve
PAI,
exogenous
contrast
agents,
form
nanomaterials,
being
used
achieve
better
image
less
side
effects,
lower
accumulation,
improved
target
specificity.
Nanomedicine
become
inevitable
management,
it
contributes
at
every
stage
diagnosis
therapy,
surgery,
even
postoperative
care
surveillance
recurrence.
Nanocontrast
agents
have
been
developed
explored
early
diagnosis.
The
systemic
stability
specificity
nanomaterials
render
its
theranostic
property
depends
various
influencing
factors
such
administration
route
physico-chemical
responsiveness.
recent
focus
targeting
lymphatic
system
nodes
diagnosis,
they
play
vital
role
progression
metastasis.
This
review
aims
discuss
advancements
using
nanoparticles
theranostics
emphasis
progression,
metastasis,
guided
tumor
resection,
finally
drug
delivery.
Journal of Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Aug. 24, 2023
Abstract
Lymph
nodes
play
a
pivotal
role
in
tumor
progression
as
key
components
of
the
lymphatic
system.
However,
unique
physiological
structure
lymph
has
traditionally
constrained
drug
delivery
efficiency.
Excitingly,
nanomedicines
have
shown
tremendous
advantages
node-specific
delivery,
enabling
distinct
recognition
and
diagnosis
nodes,
hence
laying
foundation
for
efficient
therapies.
In
this
review,
we
comprehensively
discuss
factors
affecting
specific
enrichment
systematically
summarize
precise
node
therapeutic
application,
including
treatment
nanodrugs
imaging
identification
Notably,
delve
into
critical
challenges
considerations
currently
facing
nanomedicines,
futher
propose
effective
strategies
to
address
these
issues.
This
review
encapsulates
recent
findings,
clinical
applications,
future
prospects
designing
nanocarriers
system
targeting,
with
potential
implications
improving
cancer
strategies.